Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01814241 · ClinicalTrials.gov registry record · Phase 2
Mechanisms of Desensitization During Peanut Oral Immunotherapy
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01814241 is a Phase 2 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 20 participants.
The verdict
NCT01814241, a Phase 2 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to attempt to understand how desensitization works in peanut allergic children who are undergoing oral immunotherapy (OIT) to peanut. We want to identify the early changes in the desensitization process the immune cells undergo to become desensitized to the peanut protein.
Interventions
- DRUG Open label peanut OIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01814241
The ClinicalTrials.gov registry entry for NCT01814241 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Open label peanut OIT is the first listed.
NCT01814241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01814241 about?
NCT01814241 is a clinical study titled "Mechanisms of Desensitization During Peanut Oral Immunotherapy". The purpose of this study is to attempt to understand how desensitization works in peanut allergic children who are undergoing oral immunotherapy (OIT) to peanut. We want to identify the early changes in the desensitization process the immune cells undergo to become desensitized to the peanut protei...
What is the current status of trial NCT01814241?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2013-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01814241?
The interventions under investigation include: Open label peanut OIT (DRUG).
Who is sponsoring clinical trial NCT01814241?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.